In vitro reduction of mycotoxins and other inflammatory mediators from whole blood using CytoSorb® hemoadsorbent polymer beads
Scheirer A.R., Rueggeberg K.-G., Golobish T.D., Guliashvili T., Gruda M.C., O’Sullivan P., Chan P.P., CytoSorbents Corporation, US
Opportunistic fungal infections account for up to 25% of all hospital-acquired blood infections. Patients at highest risk are those with weakened immune systems, and include elderly patients, patients with cancer or HIV infection, and patients [...]